Iron in chronic brain disorders: Imaging and neurotherapeutic implications

被引:234
作者
Stankiewicz, James
Panter, S. Scott
Neema, Mohit
Arora, Ashish
Batt, Courtney E.
Bakshi, Rohit
机构
[1] Brigham & Womens Hosp, Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA
[3] Univ Calif San Francisco, Vet Adm Hosp, Dept Neurol Surg, San Francisco, CA 94121 USA
关键词
iron; neurodegeneration; MRI; chelation; Alzheimer's disease; Parkinson's disease; multiple sclerosis;
D O I
10.1016/j.nurt.2007.05.006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Iron is important for brain oxygen transport, electron transfer, neurotransmitter synthesis, and myelin production. Though iron deposition has been observed in the brain with normal aging, increased iron has also been shown in many chronic neurological disorders including Alzheimer's disease, Parkinson's disease, and multiple sclerosis. In vitro studies have demonstrated that excessive iron can lead to free radical production, which can promote neurotoxicity. However, the link between observed iron deposition and pathological processes underlying various diseases of the brain is not well understood. It is not known whether excessive in vivo iron directly contributes to tissue damage or is solely an epiphenomenon. In this article, we focus on the imaging of brain iron and the underlying physiology and metabolism relating to iron deposition. We conclude with a discussion of the potential implications of iron-related toxicity to neurotherapeutic development.
引用
收藏
页码:371 / 386
页数:16
相关论文
共 184 条
[1]  
Aguirre P, 2006, BIOL RES, V39, P103, DOI 10.4067/S0716-97602006000100012
[2]   Green tea epigallocatechin-3-gallate mediates T cellular NF-κB inhibition and exerts neuroprotection in autoimmune encephalomyelitis [J].
Aktas, O ;
Prozorovski, T ;
Smorodchenko, A ;
Savaskan, NE ;
Lauster, R ;
Kloetzel, PM ;
Infante-Duarte, C ;
Brocke, S ;
Zipp, F .
JOURNAL OF IMMUNOLOGY, 2004, 173 (09) :5794-5800
[3]  
Andersen J K, 2001, Novartis Found Symp, V235, P11
[4]   T2 RELAXATION-TIME IN PATIENTS WITH PARKINSONS-DISEASE [J].
ANTONINI, A ;
LEENDERS, KL ;
MEIER, D ;
OERTEL, WH ;
BOESIGER, P ;
ANLIKER, M .
NEUROLOGY, 1993, 43 (04) :697-700
[5]  
Atasoy HT, 2004, NEUROL INDIA, V52, P332
[6]   T2 hypointensity in the deep gray matter of patients with multiple sclerosis - A quantitative magnetic resonance imaging study [J].
Bakshi, R ;
Benedict, RHB ;
Bermel, RA ;
Caruthers, SD ;
Puli, SR ;
Tjoa, CW ;
Fabiano, AJ ;
Jacobs, L .
ARCHIVES OF NEUROLOGY, 2002, 59 (01) :62-68
[7]   MRI T2 shortening ('black T2') in multiple sclerosis: frequency, location, and clinical correlation [J].
Bakshi, R ;
Shaikh, ZA ;
Janardhan, V .
NEUROREPORT, 2000, 11 (01) :15-21
[8]  
BALLA G, 1991, LAB INVEST, V64, P648
[9]  
Bartzokis G, 2000, CELL MOL BIOL, V46, P821
[10]   Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases [J].
Bartzokis, G ;
Tishler, TA ;
Shin, IS ;
Lu, PH ;
Cummings, JL .
REDOX-ACTIVE METALS IN NEUROLOGICAL DISORDERS, 2004, 1012 :224-236